125 related articles for article (PubMed ID: 33381853)
1. GMP-Compatible, Xeno-Free Culture of Human Induced Mesenchymal Stem Cells.
de Peppo GM
Methods Mol Biol; 2021; 2286():121-129. PubMed ID: 33381853
[TBL] [Abstract][Full Text] [Related]
2. GMP-compatible and xeno-free cultivation of mesenchymal progenitors derived from human-induced pluripotent stem cells.
McGrath M; Tam E; Sladkova M; AlManaie A; Zimmer M; de Peppo GM
Stem Cell Res Ther; 2019 Jan; 10(1):11. PubMed ID: 30635059
[TBL] [Abstract][Full Text] [Related]
3. Suspension Culture of Human Induced Pluripotent Stem Cells in Single-Use Vertical-Wheel™ Bioreactors Using Aggregate and Microcarrier Culture Systems.
Nogueira DES; Rodrigues CAV; Hashimura Y; Jung S; Lee B; Cabral JMS
Methods Mol Biol; 2021; 2286():167-178. PubMed ID: 33381855
[TBL] [Abstract][Full Text] [Related]
4. Isolation, Culture, Cryopreservation, and Preparation of Umbilical Cord-Derived Mesenchymal Stem Cells as a Final Cellular Product Under Good Manufacturing Practices-Compliant Conditions.
Aydoğdu N; Öztel ON; Karaöz E
Methods Mol Biol; 2021; 2286():73-84. PubMed ID: 33349902
[TBL] [Abstract][Full Text] [Related]
5. Isolation, Culture, Cryopreservation, and Preparation of Skin-Derived Fibroblasts as a Final Cellular Product Under Good Manufacturing Practice-Compliant Conditions.
Aydoğdu N; Öztel ON; Karaöz E
Methods Mol Biol; 2021; 2286():85-94. PubMed ID: 33349903
[TBL] [Abstract][Full Text] [Related]
6. GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control.
Andriolo G; Provasi E; Brambilla A; Lo Cicero V; Soncin S; Barile L; Turchetto L; Radrizzani M
Methods Mol Biol; 2021; 2286():131-166. PubMed ID: 33381854
[TBL] [Abstract][Full Text] [Related]
7. The Isolation and Manufacture of GMP-Grade Bone Marrow Stromal Cells from Bone Specimens.
Dias RB; Bonfim DC
Methods Mol Biol; 2021; 2286():95-105. PubMed ID: 33534112
[TBL] [Abstract][Full Text] [Related]
8. Induced Pluripotent Stem Cell-Derived Mesenchymal Stromal Cells Are Functionally and Genetically Different From Bone Marrow-Derived Mesenchymal Stromal Cells.
Xu M; Shaw G; Murphy M; Barry F
Stem Cells; 2019 Jun; 37(6):754-765. PubMed ID: 30779868
[TBL] [Abstract][Full Text] [Related]
9. GMP-Compliant Production of Human Placenta-Derived Mesenchymal Stem Cells.
Aghayan HR; Payab M; Mohamadi-Jahani F; Aghayan SS; Larijani B; Arjmand B
Methods Mol Biol; 2021; 2286():213-225. PubMed ID: 32504292
[TBL] [Abstract][Full Text] [Related]
10. hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.
Sabapathy V; Kumar S
J Cell Mol Med; 2016 Aug; 20(8):1571-88. PubMed ID: 27097531
[TBL] [Abstract][Full Text] [Related]
11. Scalable Manufacturing of Human Hematopoietic Stem/Progenitor Cells Exploiting a Co-culture Platform with Mesenchymal Stromal Cells.
Fernandes-Platzgummer A; Andrade PZ; Cabral JMS; da Silva CL
Methods Mol Biol; 2021; 2286():107-120. PubMed ID: 32488668
[TBL] [Abstract][Full Text] [Related]
12. Swiss Fetal Transplantation Program and Non-enzymatically Isolated Primary Progenitor Cell Types for Regenerative Medicine.
Laurent A; Scaletta C; Hirt-Burri N; Raffoul W; de Buys Roessingh AS; Applegate LA
Methods Mol Biol; 2021; 2286():1-24. PubMed ID: 32430595
[TBL] [Abstract][Full Text] [Related]
13. Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies.
Dashtban M; Panchalingam KM; Shafa M; Ahmadian Baghbaderani B
Methods Mol Biol; 2021; 2286():179-198. PubMed ID: 32430594
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Media Fill Method for Solid Tissue Processing in Good Manufacturing Practice-Compliant Cell Production.
Öztel ON; Aydoğdu N; Karaöz E
Methods Mol Biol; 2021; 2286():67-71. PubMed ID: 33349901
[TBL] [Abstract][Full Text] [Related]
15. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
16. Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells from the Tasmanian Devil (
Weeratunga P; Shahsavari A; Fennis E; Wolvetang EJ; Ovchinnikov DA; Whitworth DJ
Stem Cells Dev; 2020 Jan; 29(1):25-37. PubMed ID: 31709909
[TBL] [Abstract][Full Text] [Related]
17. Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells.
Dupuis V; Oltra E
World J Stem Cells; 2021 Aug; 13(8):1094-1111. PubMed ID: 34567428
[TBL] [Abstract][Full Text] [Related]
18. In vivo regeneration of rat laryngeal cartilage with mesenchymal stem cells derived from human induced pluripotent stem cells via neural crest cells.
Yoshimatsu M; Ohnishi H; Zhao C; Hayashi Y; Kuwata F; Kaba S; Okuyama H; Kawai Y; Hiwatashi N; Kishimoto Y; Sakamoto T; Ikeya M; Omori K
Stem Cell Res; 2021 Apr; 52():102233. PubMed ID: 33607469
[TBL] [Abstract][Full Text] [Related]
19. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
[TBL] [Abstract][Full Text] [Related]
20. Induction of pluripotent stem cells by reprogramming human ocular fibroblasts under xeno-free conditions.
Xiong Y; Liu Y; Ge J
Arq Bras Oftalmol; 2018; 81(5):376-383. PubMed ID: 30208139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
